The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(May 2023)
Editorial: Measurable residual disease in hematologic malignancies
Francesco Buccisano,
Raffaele Palmieri,
Monica L. Guzman,
Sara Galimberti
Affiliations
Francesco Buccisano
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
Raffaele Palmieri
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
Monica L. Guzman
Weill Cornell Medicine, Cornell University, White Plains, NY, United States
Sara Galimberti
Division of Hematology, University Hospital of Pisa, Pisa, Italy
DOI
https://doi.org/10.3389/fonc.2023.1204393
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
MRD - measurable residual disease
multiparameter flow cytometry
polymerase chain reaction
surrogate endpoint biomarker
next generation sequencing
next generation flow cytometry (NGF)
WeChat QR code
Close